Understanding breast cancer in young Latin American women

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the molecular subtypes of premenopausal breast cancer among women in Latin America. It focuses on identifying specific risk factors, tumor characteristics, and the impact of lifestyle factors such as diet and physical activity on breast cancer incidence and mortality. By conducting a multi-center case-control study, the research seeks to gather comprehensive data that can inform preventive measures and improve treatment outcomes for this demographic. The study will include women aged 20 to 45 who have been diagnosed with primary breast cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* woman between 20 and 45 years old
* woman less than 3 years older or younger than the case
* living in the area that the study is taking place during the past 3 years
* woman menstruated at least once in the past 12 months
* woman diagnosed with a primary breast cancer by histopathological examination (only for cases)

Exclusion Criteria:

* woman receiving tumor treatment, such as radiotherapy, chemotherapy or anti-estrogens (for example, tamoxifen) (except treatment for non-melanoma skin cancers)
* woman taking (or has previously taken) any of the following medications in the past 6 months: tamoxifen, Evista (raloxifene), Fareston (toremifene), Aromasin (exemestane), Femara (letrozole), Arimidez (anastrozole) or Megace (megestrol)
* woman suffering from chronic kidney failure
* woman having a pathology that will hinder adequate communication
* woman who is pregnant or nursing
* woman who has been previously diagnosed with a cancer(except for non-melanoma skin cancers)
* any other reason to exclude

Where it's running

• Grupo Infección y Cáncer. Universidad de Antioquia
  Medellín, Antioquia, Colombia Recruiting
• International Hospital of Colombia
  Bucaramanga, Bucaramanga, Colombia Recruiting
• Hospital Internacional de Colombia Fundacion Cardiovascular de Colombia
  Bucaramanga, Colombia Recruiting
• SENOSAMA foundation
  Bucaramanga, Colombia Recruiting
• Public Health University of Narino
  Pasto, Colombia Recruiting
• Barretos Cancer Hospital
  Barretos, Brazil Completed

Study contacts

• Principal investigator: Sabina Rinaldi, PhD — International Agency for Research on Cancer, Lyon, France
• Study coordinator: Sabina Rinaldi, PhD
• Email: rinaldis@iarc.who.int
• Phone: +33 472738485

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oncoliq blood test for early detection of breast cancer

  This project will test whether a blood-based miRNA panel (the Oncoliq Test) can detect early breast cancer in adults 40–70 by comparing newly diagnosed, untreated patients with cancer-free controls.

  Recruiting Oncoliq US Inc · Buenos Aires, Buenos Aires · NCT07331506

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• Negative pressure wound therapy after mastectomy

  This study tests whether a negative pressure dressing after mastectomy reduces fluid build‑up and common wound complications in women with breast cancer.

  Recruiting Dalarna County Council, Sweden · Falun · NCT07607366

• ATUSA 3D automated breast ultrasound for suspicious breast lesions

  This study will test whether the ATUSA 3D automated breast ultrasound system can produce high-quality images that match biopsy results in women with BI-RADS 4 or 5 breast findings.

  Recruiting at 2 sites iSono Health, Inc. · Sacramento, California and 1 other locations · NCT07505797

• Support tool for women with HR+ breast cancer on long-term endocrine therapy

  This study tests a SHIELD web- and app-based portal to help women with hormone receptor–positive breast cancer manage symptoms while on long-term endocrine treatment.

  Recruiting Dana-Farber Cancer Institute · Boston, Massachusetts · NCT07482384

• Conformal ablative radiotherapy for older women with localized ER-positive, HER2-negative breast cancer choosing non-surgical care

  This study will test whether five focused SABR treatments can control ER-positive, HER2-negative breast tumors up to 5 cm in women aged 65 and older who are opting for non-surgical management.

  Recruiting University of Kansas Medical Center · Kansas City, Kansas and 1 other locations · NCT07242118

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.